Pen Needles Market size was valued at USD 1.5 Bn. in 2021 and the total Pen Needles revenue is expected to grow by 11.5 % from 2022 to 2029, reaching nearly USD 3.5 Bn.
North America is expected to account for the highest share for players operating in the pen needles market
In October 2020, Arkray Inc. (Japan) launched TechLITE Pen Needles which are now indicated for use with pen injector devices for the subcutaneous injection of drugs in the US.
In October 2020, Arkray Inc. (Japan) launched TechLITE Pen Needles which are now indicated for use with pen injector devices for the subcutaneous injection of drugs in the US.
North America is expected to account for the highest share for players operating in the Pen Needles Market.
Novo Nordisk A/S (Denmark) holds the second position in 2020. The company’s Diabetes Care segment, which offers safety pen needles (NovoFine Autocover) and standard pen needles (NovoFine Plus and NovoTwist), is its largest and fastest-growing business.
North America is expected to account for the largest share of the pen needles market in 2020
North America is expected to account for the largest share of the pen needles market in 2020
In January 2019, Becton, Dickinson and Company (US) launched Second Generation Standard Pen Needles.
North America dominated the pen needles market in 2018
The standard pen needles segment is expected to account for the largest share of the Pen Needles Market
The insulin therapy segment to grow at the highest CAGR during the forecast period.
The 8mm segment accounted for the largest share of the pen needles market
The insulin therapy segment to grow at the highest CAGR during the forecast period
The insulin therapy segment to grow at the highest CAGR during the forecast period.
The insulin therapy segment is expected to grow at the highest CAGR during the forecast period
North America dominated the pen needles market.
North America dominated the pen needles market
North America dominated the pen needles market.
North America dominated the pen needles market in 2018
North America dominated the pen needles market in 2018
Pen Needles Market by Type (Standard Pen Needles and Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - Global Forecast to 2024
North America dominated the pen needles market in 2018
North America dominated the pen needles market in 2018
The growing preference for biosimilar drugs is another factor providing a wide range of growth opportunities for key players in the market.
Growth in the market is mainly driven by factors such as the growing prevalence of chronic diseases and the favorable reimbursement scenario in selected countries.
Pen Needles Market is expected to reach USD 1.8 billion by 2024 from an estimated USD 1.1 billion in 2019, at a CAGR of 10.8% during the forecast period (2019–2024).
Pen Needles Market is expected to reach USD 3.4 billion by 2023 from an estimated USD 2.0 billion in 2018, at a CAGR of 11.0% during the forecast period (2018–2023)
The pen needles market is expected to reach USD 3.4 billion by 2023 from an estimated USD 2.0 billion in 2018, at a CAGR of 11.0% during the forecast period (2018–2023).
The Pen Needles Market is expected to reach USD 2.81 Billion will be growing at a CAGR of 11.2%.
According to the new market research report “Pen Needles Market by Type (Standard Pen Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail)
“The pen needles market is expected to reach USD 2.81 Billion by 2021 from USD 1.65 Billion in 2016, growing at a CAGR of 11.2% from 2016 to 2021”.